Considering the importance that the ratio CANP/calpastatin plays in regulating CANP activation and the contribution of calpains to the development of MS, this result is extremely important since it may suggest that IFN-β may also act by counteracting the increase of CANP/calpastatin ratio. The gene discussed is CAST; the disease is myeloid sarcoma.